Early Clinical Signs and the Evolution of Diagnosis in Wilson Disease

This episode, titled 'Early Clinical Signs and the Evolution of Diagnosis in Wilson Disease,' features panelists discussing the standard and evolving protocols for identifying Wilson disease in various patient populations. Dr. Rima Fawaz explains that while elevated alanine aminotransferase (ALT) remains the most common signal for a pediatric workup, the medical community is entering a new era shaped by preconception genetic testing and advanced screening. The discussion highlights a pilot neonatal screening program in Washington state that measures ATP7B protein peptides. Although this testing offers the potential to catch patients before they become symptomatic, the experts note current limitations, including false positives and the need for more robust data.

The conversation also addresses how age influences the clinical profile of the disease. While younger children primarily present with hepatic symptoms, neurological manifestations such as tremors and hyperkinetic movements typically emerge in pre-teen years or young adulthood. Dr. Peter Hedera notes that as patients age, they may trend toward hypokinetic movements, though the disease remains highly heterogeneous.

To differentiate Wilson disease from other movement disorders like Parkinson’s, the panel emphasizes a multi-modal diagnostic approach. Because clinical signs alone are often nonspecific, experts rely on a suite of confirmatory tests, including ceruloplasmin levels, 24-hour urine copper, and non-ceruloplasmin copper (NCC) assays. They also discuss the utility of neuroimaging for detecting T2 signal changes in the basal ganglia and the importance of ophthalmological exams to identify Kayser-Fleischer rings. The episode concludes by reinforcing that because Wilson disease is such a persistent masquerader, clinicians must maintain a low threshold for laboratory evaluation to avoid missing a diagnosis.

In the next episode, 'Multidisciplinary Collaboration and Diagnostic Frameworks in Wilson Disease,' panelists will continue their discussion on Wilson disease and highlight the importance of a team-based approach involving hepatologists, neurologists, and psychiatrists. The conversation covers the practical application of the Leipzig score and the growing role of next-generation sequencing in identifying preclinical cases.